“osage-university-partners” Archives

in
Entry Author Date Location
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
Gilead Grabs Option to Acquire Pionyr & Its Clinic-Bound Immunotherapies 06/23/20 San Francisco
With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases 03/26/20 San Francisco
ArsenalBio Launches With $85M for “Programmable” T Cell Therapies 10/17/19 San Francisco
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug 10/15/19 Boston
Everactive Snags $30M Series C to Advance Battery-less IoT Sensors 06/25/19 Detroit Ann Arbor
With Yale Tech and $12M, Artizan Aims for Root Cause of Gut Disease 06/10/19 Boston
San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More 05/17/19 San Diego
Seattle Algorithm Marketplace and Manager, Algorithmia, Snags $25M 05/14/19 Texas
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
TX Tech News: Techstars Austin, Essentium, Ontic, & More Startup Funds 01/25/19 Texas
Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer 01/04/19 Boston
Synthorx Gets $131M in Upsized IPO for Synthetic Biology Drugs 12/07/18 San Diego
CEOs and Scientific Founders: Tips for a Long and Successful Marriage 11/13/18 New York
Millendo Therapeutics Goes Public With OvaScience Reverse Merger 08/09/18 Detroit Ann Arbor
Precision Bio Lands $110M as Gene-Edited Cell Therapy Nears Clinic 06/27/18 Raleigh Durham
With $40M Banked, Escient Building for Fast Move to Human Trials 06/01/18 San Diego
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs 04/30/18 San Diego
E-Scape Unveils $63M for Alzheimer’s, Parkinson’s Drug Research 07/12/17 San Francisco
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Aiming At P53, Cancer’s Hard Target, PMV Pharma Raises $74M 02/22/17 New York
KenSci Raises $8.5M, Delves into Data to Predict Who Will Get Sick 01/25/17 Seattle
Celldex, Aiming For More Cancer Drug Combos, Pays $62.5M For Kolltan 11/01/16 New York
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer 03/03/16 Boston
Kymeta Raises $62M, Demonstrates Satellite Antenna on Toyota Car Roof 01/12/16 Seattle
Avalon, TPG Lead $15M Deal to Advance Metformin as Cancer Drug 12/03/15 San Diego
Bristol-Myers to Add Cardioxyl’s Heart Failure Drug With $300M Deal 11/02/15 Raleigh Durham
With New CEO, Seattle’s Faraday Pharma Aims to Exploit Ikaria Roots 09/03/15 Seattle
Precision BioSciences Lands $26M for Gene-Editing Technology 05/11/15 Raleigh Durham
Page 1 of 2 next page »